Eczema: injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, dry eye, cold sores in your mouth or on your lips, and high count of a certain white blood cell (eosinophilia). Asthma: injection site reactions, high count ...
Too much IL-4 and IL-13 activity can cause swelling in parts of your body that lead to asthma, COPD, eczema, and other conditions. Blocking IL-4 and IL-13 from working can decrease the swelling that causes these conditions. How is Dupixent supplied (dosage forms)? Dupixent is available ...
If you are using Dupixent for either asthma or eczema, you may be at risk for a condition calledpsoriasis. Talk to your health care provider if you get any new skin problems, even months after starting this medicine. What should I tell my healthcare provider before using Dupixent?
Eczema Herpeticum And Herpes Zoster The rate of eczema herpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zoster was reported in <1% of the DUPIXENT groups (1 per 100 subjec...
Eczema Herpeticum And Herpes Zoster The rate of eczema herpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zoster was reported in <1% of the DUPIXENT groups (1 per 100 subjec...
Eczema Herpeticum And Herpes Zoster The rate of eczema herpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zoster was reported in <1% of the DUPIXENT groups (1 per 100 subjec...
Eczema Herpeticum And Herpes Zoster The rate ofeczemaherpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zosterwas reported in <1% of the DUPIXENT groups (1 per 100 subject-ye...
Eczema Herpeticum And Herpes Zoster The rate ofeczemaherpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zosterwas reported in <1% of the DUPIXENT groups (1 per 100 subject-ye...
Eczema Herpeticum And Herpes Zoster The rate of eczema herpeticum was similar in the placebo and DUPIXENT groups in the AD trials. The rates remained stable through 260 weeks in the long-term OLE trial (AD-1225). Herpes zoster was reported in <1% of the DUPIXENT groups (1 per 100 subjec...